Cure My Disease

Don't miss your cure!

 Log in / Sign up

Could one surgery be enough? new trial aims to cut unnecessary procedures for bladder cancer patients

NCT ID NCT05962541

Recruiting now Disease control Sponsor: University of Roma La Sapienza Source: ClinicalTrials.gov ↗

First seen Jan 06, 2026 · Last updated May 15, 2026 · Updated 24 times

Summary

This study compares a newer, single surgery using special dye and light (PDD-TURBT) against the standard approach of two surgeries for early-stage bladder cancer. About 112 adults with non-muscle invasive bladder cancer will be randomly assigned to either the new single-surgery method or the standard two-surgery method. The goal is to see if the single surgery is just as effective at preventing cancer from coming back, while avoiding an unnecessary second operation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON MUSCLE INVASIVE BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • AOU Policlinico Umberto I Hospital, UOC Urologia SMUC05, Rome, Italy

    RECRUITING

    Rome, Lazio, 00161, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HIGH RISK NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA NON MUSCLE INVASIVE BLADDER CANCER NON-MUSCLE INVASIVE BLADDER UROTHELIAL CARCINOMA